男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

COVID-19 vaccine from Anhui earns conditional approval

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2022-03-02 17:20
Share
Share - WeChat
Workers of Anhui Zhifei Longcom Biopharmaceutical Co Ltd check packaged drugs at the company's plant in Hefei, Anhui province, in May. [Photo/Xinhua]

China has given conditional approval for a recombinant protein subunit COVID-19 vaccine developed by domestic company Anhui Zhifei Longcom Biopharmaceutical, the National Medical Products Administration said on Wednesday.

The vaccine uses purified pieces of the virus' protein to trigger an immune response. It is the first vaccine based on this technology to be approved by the top drug regulator.

In total, five COVID-19 vaccines have been approved for public use in China so far.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 鹤岗市| 佛坪县| 昌平区| 鲜城| 炉霍县| 遂川县| 博白县| 本溪| 称多县| 华宁县| 夏河县| 望都县| 依安县| 建宁县| 淳化县| 通州市| 乐亭县| 佳木斯市| 庆云县| 兖州市| 伊宁县| 宁武县| 香河县| 平山县| 阿勒泰市| 宁强县| 都昌县| 抚顺县| 乌拉特后旗| 潼南县| 荆州市| 扎鲁特旗| 湛江市| 林甸县| 沙田区| 巴中市| 井冈山市| 铜山县| 佛冈县| 万全县| 金沙县|